Concepedia
Statistics
Publications
11
Citations
478
H-Index
Active since
2009
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
VA Boston Healthcare System
Wayne State University
The Barbara Ann Karmanos Cancer Institute
Jagannath Pal is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and life sciences.
Publications per year
2009–2023
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
Sanjeev Kumar, Christopher S. Bryant, Sreedhar Chamala et al. · Molecular Cancer · 2009 · 92 citations · Full text
Medicine, Oncology, Pharmacology +14
Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy
Aamer Qazi, Jagannath Pal, Ma'in Y. Maitah et al. · Translational Oncology · 2010 · 86 citations · Full text
Medicine, Oncology, Pharmacology +17
Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells
Christopher S. Bryant, Sanjeev Kumar, Sreedhar Chamala et al. · Molecular Cancer · 2010 · 73 citations · Full text
Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome
Jagannath Pal, Robert C. Bertheau, Leutz Buon et al. · Oncogene · 2011 · 63 citations
Life Sciences, Genetics, Molecular Biology +14
Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance
Subodh Kumar, Srikanth Talluri, Jagannath Pal et al. · Blood Cancer Journal · 2018 · 53 citations · Full text
Medicine, Molecular Biology, Oncology +16
1–5 of 11